This inventor holds 20 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Genomic Analysis. Top assignees: Pacific Biosciences of California, Inc., Foundation Medicine, Inc., Genentech, Inc.. Active years: 2009-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Carlos, CA (US) (2011 - 2013)
- Santa Clara, CA (US) (2009 - 2015)
- Brookline, MA (US) (2013 - 2022)
- Cambridge, MA (US) (2023 - 2024)
Company Filing History:
11 out of 439 
9 out of 47 
1 out of 3,302 
Years Active: 2009-2026
Areas of Expertise:
Title: Innovations by Geoffrey Alan Otto: A Pioneer in Tumor Analysis
Introduction
Geoffrey Alan Otto, an accomplished inventor based in Brookline, MA, has made significant contributions to the field of tumor analysis and genetics. With a portfolio of 18 patents, Otto has been at the forefront of innovative methods for evaluating tumor samples, ultimately aiming to advance medical diagnostics and treatment.
Latest Patents
Among his most notable inventions are two recent patents focusing on the optimization of multigene analysis of tumor samples. These patents detail methods for analyzing tumor samples to provide a clonal profile of a subject's genetic makeup, specifically addressing subgenomic intervals and expressed subgenomic intervals. This innovative approach enhances the understanding of tumor characteristics and paves the way for more personalized therapies.
Career Highlights
Throughout his career, Geoffrey Alan Otto has worked with notable companies, including Pacific Biosciences of California, Inc. and Foundation Medicine, Inc. His experience in these organizations has allowed him to develop cutting-edge methodologies that are instrumental in the field of precision medicine and oncology.
Collaborations
Otto's work has often been collaborative, as seen through his partnerships with esteemed colleagues such as Stephen Wilson Turner and Doron Lipson. Together, they have contributed to advancements in the analysis of genetic data, pushing the boundaries of what is possible in cancer research and treatment.
Conclusion
Geoffrey Alan Otto stands out as a significant figure in the realm of innovations related to tumor analysis. His contributions through patents and collaborative efforts exemplify the critical role inventors play in revolutionizing healthcare. The methods developed by Otto not only enhance our understanding of tumors but also represent a leap forward in providing personalized medical solutions for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile